Ke Wu to Antineoplastic Agents
This is a "connection" page, showing publications Ke Wu has written about Antineoplastic Agents.
Connection Strength
0.742
-
Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, Vadgama JV, Wu Y. Targeting of PP2Cd By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo. Antioxid Redox Signal. 2019 06 10; 30(17):1983-1998.
Score: 0.322
-
Zakaria MB, Belik AA, Liu CH, Hsieh HY, Liao YT, Malgras V, Yamauchi Y, Wu KC. Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic-Guided Chemotherapy. Chem Asian J. 2015 Jul; 10(7):1457-62.
Score: 0.260
-
Le KV, Nguyen HT, Pham PQ, Nguyen NH, Doan TLH, Nguyen LHT, Phan BT, Nguyen LTM, Park S, Pham NK, Krisbiantoro PA, Wu KC, Mai NXD. Biogenic fluorescent carbon dot-decorated mesoporous organosilica nanoparticles for enhanced bioimaging and chemotherapy. Nanoscale Horiz. 2025 Apr 22; 10(5):1000-1006.
Score: 0.129
-
Yadav A, Hiremath N, Saini B, Matsagar BM, Han PC, Ujihara M, Modi MH, Wu KC, Sharma RK, Vankayala R, Dutta S. Coordinately unsaturated single Fe-atoms with N vacancies and enhanced sp3 carbon defects in Fe-N(sp2)-C structural units for suppression of cancer cell metabolism and electrochemical oxygen evolution. Nanoscale. 2024 Nov 28; 16(46):21416-21430.
Score: 0.031